Itau Unibanco Holding S.A. Arrowhead Pharmaceuticals, Inc. Transaction History

Itau Unibanco Holding S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$21.87 - $28.24 $3,039 - $3,925	139 New	139 $3,000
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $678 - $992	-32 Reduced 18.29%	143 $4,000
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $52 - $72	-2 Reduced 1.13%	175 $4,000
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $478 - $786	-19 Reduced 9.69%	177 $6,000
Q4 2022 Feb 09, 2023	SELL	$28.0 - $40.56 $728 - $1,054	-26 Reduced 11.71%	196 $7,000
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $166 - $303	-6 Reduced 2.63%	222 $8,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $5,111 - $7,260	-88 Reduced 27.85%	228 $15,000
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $467 - $679	8 Added 2.6%	316 $20,000
Q2 2021 Aug 17, 2021	BUY	$62.15 - $90.32 $19,142 - $27,818	308 New	308 $26,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.